Your browser doesn't support javascript.
loading
HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.
Manglani, Mamta V; Gabhale, Yashwant R; Lala, Mamatha M; Sekhar, Rohini; More, Dipti.
Afiliação
  • Manglani MV; Pediatric Centre of Excellence for HIV Care (PCoE), Department of Pediatrics, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, India.
  • Gabhale YR; Pediatric Centre of Excellence for HIV Care (PCoE), Department of Pediatrics, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, India. Correspondence to: Dr. Yashwant R. Gabhale, Deputy Program Director, Pediatric Centre of Excellence for HIV Care (PCoE), Lokmanya Tilak Mu
  • Lala MM; Pediatric Centre of Excellence for HIV Care (PCoE), Department of Pediatrics, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, India.
  • Sekhar R; Pediatric Centre of Excellence for HIV Care (PCoE), Department of Pediatrics, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, India.
  • More D; Pediatric Centre of Excellence for HIV Care (PCoE), Department of Pediatrics, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, India.
Indian Pediatr ; 55(2): 140-141, 2018 02 15.
Article em En | MEDLINE | ID: mdl-29242412
ABSTRACT

OBJECTIVE:

To determine the prevalence of HLA-B*5701 allele in HIV-infected children, and to find its association with Abacavir hypersensitivity.

METHODS:

Children (2 to 18 y) already on, or to be initiated on Abacavir were included for PCR sequencing to detect HLA-B*5701. OUTCOME MEASURES WERE proportion with HLA B*5701 allele and hypersensitivity with Abacavir. Abacavir was stopped if patient tested positive for HLA-B*5701 allele.

RESULTS:

100 children (median age 11 y) were enrolled; 10 were already on Abacavir. HLA-B*5701 positivity was observed in 11 (11%) children. Two of these 11 children developed hypersensitivity after initiation of Abacavir. Abacavir was thereafter stopped in all who tested HLA-B*5701 positive, irrespective of the development of hypersensitivity reaction.

CONCLUSION:

HLA-B*5701 allele was present in 11 (11%) of HIV-infected children, of which two developed Abacavir hypersensitivity. None of the patients without the allele developed hypersensitivity.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Didesoxinucleosídeos / Antígenos HLA-B / Infecções por HIV / Fármacos Anti-HIV / Hipersensibilidade a Drogas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Didesoxinucleosídeos / Antígenos HLA-B / Infecções por HIV / Fármacos Anti-HIV / Hipersensibilidade a Drogas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article